Term ends Jun 7, 2031 · Medium confidence
20-year base term ends Jul 6, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,857,562, US 11,865,080), so the cap could be lower.
Jul 6, 2011
Jun 7, 2031
Dec 19, 2023
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 1 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 6, 2011, when application PCT/US2011/043096, the earliest non-provisional in its chain, was filed (this one was filed Dec 13, 2022) | Jul 6, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,487,332, US 10,532,067, US 11,291,682, US 11,324,770, US 11,596,645, US 11,655,475, US 11,666,534, US 11,739,334, US 11,766,401, US 11,857,562, US 11,865,080, US 11,883,534, US 11,913,001, US 12,186,333, US 9,254,265, US 9,770,463, US 9,801,897) | capped to Jun 7, 2031 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 7, 2031 | Medium confidence |
This family
| Application PCT/US2011/043096 | PCT application no patent term | no patent term |
| US 10,487,332 | In force Jul 2031 | Jul 2031 |
| US 11,655,475 | In force Jun 2031 | Jun 2031 |
| US 11,913,001 | In force Jun 2031 | Jun 2031 |
| US 11,739,334 | In force Jun 2031 | Jun 2031 |
| US 11,773,395 | In force Jun 2031 | Jun 2031 |
| US 11,845,925 | this patent Jun 2031 | Jun 2031 |
| US 11,851,660 | In force Jun 2031 | Jun 2031 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2022 Reel 62082, frame 622 | Geall, Andrew | Novartis Vaccines and Diagnostics | Assignment of Assignor's Interest |
| Dec 14, 2022 Reel 62082, frame 678 | Novartis Vaccines and Diagnostics | Novartis AG | Assignment of Assignor's Interest |
| Dec 14, 2022 Reel 62082, frame 768 | Novartis AG | GlaxoSmithKline Biologicals S.A. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,487,332, US 10,532,067, US 11,291,682, US 11,324,770, US 11,596,645, US 11,655,475, US 11,666,534, US 11,739,334, US 11,766,401, US 11,857,562, US 11,865,080, US 11,883,534, US 11,913,001, US 12,186,333, US 9,254,265, US 9,770,463, US 9,801,897.